Vergoeding 2017-2021 voor ATC-subgroep S01EE : Prostaglandine-analoga
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| S01EE01 Latanoprost (Monoprost ®) | 2.301.300 | 2.838.100 | 3.709.600 | 3.947.700 | 3.778.000 |
| S01EE03 Bimatoprost (Lumigan ®) | 2.805.400 | 2.322.000 | 2.295.900 | 2.171.000 | 1.971.900 |
| S01EE04 Travoprost (Travatan ®) | 3.167.600 | 2.193.500 | 1.588.000 | 1.304.700 | 1.135.400 |
| S01EE05 Tafluprost (Saflutan ®) | 1.925.000 | 1.878.800 | 1.890.200 | 1.779.600 | 1.554.900 |
| Totaal | 10.199.300 | 9.232.400 | 9.483.700 | 9.203.000 | 8.440.200 |